Skip to main content
. Author manuscript; available in PMC: 2012 May 16.
Published in final edited form as: J Infect Dis. 2009 May 1;199(9):1275–1285. doi: 10.1086/597808

Table 5.

Stop codons detected at a prevalence of ≥2% by direct polymerase chain reaction sequencing or ultra-deep pyrosequencing.

Samples from NRTI-naive patients (HBV type), %
Samples from NRTI-treated patients (HBV type), %
S protein RT Mutation 7774-0 (A) A7 (B) B1 (B) B5 (B) C2 (C) C7 (C) D3 (A) 7774-1 (A) 7774-2 (A) 1329-1 (A) 1329-2 (A) C5 (B) 26278-1 (G) 26278-2 (G) 26278-3 (G) HTT (B) 1284-2 (G)
W35* Silent 2.3

W36* Silent 2.5

S61* Silent 5.6

C69* Silent 31

W74* Silent 43 19 26 27 27

C107* S116T 19 7.7 62

W172* A181T 4.1

W182* V191I 41 3.1 2.9 2.9 5.4 5.3 3.6

W191* Silent 2.5 2.0

W196*a Silent/M204I 3.0 52 56 51

W199*a Silent/V207I 3.1 3.7 51 55 49

W201* Silent 52 54 49

L216* Silent 35 9.8 73 22 33 14

NOTE. Data are the percentage of ultra-deep pyrosequencing reads with a stop codon at that position. Underlining indicates stop codons that were also detected by direct polymerase chain reaction sequencing.

a

Depending on the genetic context, W196* and W199* can be caused by M204I and M207I, respectively, or by silent reverse-transcriptase (RT) mutations.